Skip to main content

Advertisement

SpringerLink
Log in

Breast Cancer Treatment and Cognitive Functioning: Current Status and Future Challenges in Assessment

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. TA Ahles AJ Saykin (2001) ArticleTitleCognitive effects of standard-dose chemotherapy in patients with cancer Cancer Invest 19 821–820 Occurrence Handle10.1081/CNV-100107743 Occurrence Handle11768036

    Article  PubMed  Google Scholar 

  2. CA Meyers (2000) ArticleTitleNeurocognitive dysfunction in cancer patients Oncology 14 75–79 Occurrence Handle10680150

    PubMed  Google Scholar 

  3. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor (2005) ArticleTitleCancer Statistics, 2005 CA: A Cancer J Clin 55 10–30

    Google Scholar 

  4. SA Castellon P Ganz (2001) ArticleTitleCognitive function following adjuvant treatment for breast cancer Oncology 15 622–624

    Google Scholar 

  5. PA Ganz JH Rowland K Desmond BE Meyerowitz GE Wyatt (1998) ArticleTitleLife after breast cancer: understanding women’s health-related quality of life and sexual functioning J Clin Oncol 16 501–514 Occurrence Handle9469334

    PubMed  Google Scholar 

  6. PA Ganz KA Desmond B Leedham JH Rowland BE Meyerowitz TR Belin (2002) ArticleTitleQuality of life in long-term, disease-free survivors of breast cancer: a follow-up study J Natl Cancer Inst 94 39–49 Occurrence Handle11773281

    PubMed  Google Scholar 

  7. K Phillips J Bernhard (2003) ArticleTitleAdjuvant breast cancer treatment and cognitive function: current knowledge and research directions J Natl Cancer Inst 95 190–197 Occurrence Handle12569140

    PubMed  Google Scholar 

  8. JD Bremner P Randall TM Scott RA Bronen JP Seibyl SM Southwick RC Delaney G McCarthy DS Charney RB Innis (1995a) ArticleTitleMRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder Am J Psychiatry 152 973–981

    Google Scholar 

  9. JD Bremner JH Krystal SM Southwick DS Charney (1995b) ArticleTitleFunctional neuroanatomical correlates of the effects of stress on memory J Trauma Stress 8 527–553

    Google Scholar 

  10. TV Gurvits M Shenton H Hokama H Ohta N Lasko M Gilbertson SP Orr R Kikinis F Jolesz RW McCarley RK Pitman (1996) ArticleTitleMagnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder Biol Psychiatr 40 1091–1099 Occurrence Handle10.1016/S0006-3223(96)00229-6

    Article  Google Scholar 

  11. TA Ahles AJ Saykin C Furstenberg B Cole L Mott K Skalla MB Whedon S Bivens T Mitchell ER Greenberg PM Silberfarb (2002) ArticleTitleNeuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma J Clin Oncol 20 485–493 Occurrence Handle10.1200/JCO.20.2.485 Occurrence Handle11786578

    Article  PubMed  Google Scholar 

  12. CB Brezden KA Phillips M Abdolell T Bunston IF Tannock (2000) ArticleTitleCognitive function in breast cancer patients receiving adjuvant chemotherapy J Clin Oncol 18 2695–2701 Occurrence Handle10894868

    PubMed  Google Scholar 

  13. SA Castellon P Ganz J Bower L Petersen L Abraham GA Greendale (2004) ArticleTitleNeurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen J Clin Exp Neuropsychol 26 955–969 Occurrence Handle15742545

    PubMed  Google Scholar 

  14. FS Dam Particlevan SB Schagen MJ Muller W Boogerd E vd Wall ME Droogleever Fortuyn S Rodenhuis (1998) ArticleTitleImpairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy J Natl Cancer Inst 90 210–218 Occurrence Handle10.1093/jnci/90.3.210 Occurrence Handle9462678

    Article  PubMed  Google Scholar 

  15. N Tchen HG Juffs FP Downie Y Qi-Long H Hu I Chemerynsky M Clemons M Crump PE Goss D Warr ME Tweedale IF Tannock (2003) ArticleTitleCognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer J Clin Oncol 21 4175–4183 Occurrence Handle10.1200/JCO.2003.01.119 Occurrence Handle14615445

    Article  PubMed  Google Scholar 

  16. JS Wefel R Lenzi RL Theriault CA Meyers (2004) ArticleTitleThe cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial Cancer 100 2292–2299 Occurrence Handle10.1002/cncr.20272 Occurrence Handle15160331

    Article  PubMed  Google Scholar 

  17. AE Budson BH Price (2005) ArticleTitleMemory dysfunction N Engl J Med 352 692–699 Occurrence Handle10.1056/NEJMra041071 Occurrence Handle15716563

    Article  PubMed  Google Scholar 

  18. Schacter DL, Wagner AD, Buckner RL: Memory systems of 1999. In: Tulving E, Craik FM (eds) The Oxford Handbook of Memory. Oxford University Press, New York, 2000

  19. LR Squire SM Zola (1996) ArticleTitleStructure and function of declarative and non-declarative memory systems Proc Natl Acad Sci USA 93 13515–13522 Occurrence Handle10.1073/pnas.93.24.13515 Occurrence Handle8942965

    Article  PubMed  Google Scholar 

  20. CM Bottino CC Castro RL Gomes CA Buchpiguel RL Marchetti MR Neto (2002) ArticleTitleVolumetric MRI measurements can differentiate Alzheimer’s disease, mild cognitive impairment, and normal aging Int Psychogeriatr 14 59–72 Occurrence Handle10.1017/S1041610202008281 Occurrence Handle12094908

    Article  PubMed  Google Scholar 

  21. S Santi ParticleDe MJ Leon Particlede H Rusinek A Convit CY Tarshish A Roche WH Tsui E Kandil M Boppana K Daisley GJ Wang D Schlyer J Fowler (2001) ArticleTitleHippocampal formation glucose metabolism and volume losses in MCI and AD Neurobiol Aging 22 529–39 Occurrence Handle10.1016/S0197-4580(01)00230-5 Occurrence Handle11445252

    Article  PubMed  Google Scholar 

  22. AT Du N Schuff D Amend MP Laakso YY Hsu WJ Jagust K Yaffe JH Kramer B Reed D Norman HC Chui MW Weiner (2001) ArticleTitleMagnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease J Neurol Neurosurg Psychiatry 71 441–447 Occurrence Handle10.1136/jnnp.71.4.441 Occurrence Handle11561025

    Article  PubMed  Google Scholar 

  23. CJ Galton K Patterson K Graham MA Lambon-Ralph G Williams N Antoun BJ Sahakian JR Hodges (2001) ArticleTitleDiffering pattern of temporal atrophy in Alzheimer’s disease and semantic dementia Neurology 57 216–225 Occurrence Handle11468305

    PubMed  Google Scholar 

  24. CR Jack SuffixJr MM Shiung JL Gunter PC O’Brien SD Weigand DS Knopman BF Boeve RJ Ivnik GE Smith RH Cha EG Tangalos RC Petersen (2004) ArticleTitleComparison of different MRI brain atrophy rate measures with clinical disease progression in AD Neurology 62 591–600 Occurrence Handle14981176

    PubMed  Google Scholar 

  25. RJ Killiany BT Hyman T Gomez-Isla M Moss R Kikinis F Jolesz R Tanzi K Jones MS Albert (2002) ArticleTitleMRI measures of entorhinal cortex vs hippocampus in preclinical AD Neurology 58 1188–1196 Occurrence Handle11971085

    PubMed  Google Scholar 

  26. DH Silverman CJ Dy SA Castellon BS Pio L Abraham K Waddell ME Phelps PA Ganz (2004) ArticleTitleAltered frontocortical and basal ganglia activity in chemotherapy and tamoxifen-treated breast cancer survivors 5 to 10 years after end of chemotherapy J Nucl Med 45 67

    Google Scholar 

  27. AJ Saykin TA Ahles BC McDonald (2003) ArticleTitleMechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives Semin Clin Neuropsychiatry 8 201–216 Occurrence Handle10.1053/scnp.2003.50002 Occurrence Handle14613048

    Article  PubMed  Google Scholar 

  28. Wagner L, Sweet J, Cella D, Havlin K, Forrestal S, Parrish T, Gitelman DR: 2004. The performance of cognitively impaired oncology patients and normal controls on functional MRI. Paper presented at the annual meeting of the American Society of Clinical Oncology, New Orleans, LA.

  29. JL Eberling C Wu R Tong-Turnbeaugh WJ Jagust (2004) ArticleTitleEstrogen and Tamoxifen-associated effects on brain structure and function Neuroimage 21 364–371 Occurrence Handle10.1016/j.neuroimage.2003.08.037 Occurrence Handle14741674

    Article  PubMed  Google Scholar 

  30. SB Schagen FS Dam Particlevan MJ Muller W Boogerd J Lindeboom PF Bruning (1999) ArticleTitleCognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85 640–650 Occurrence Handle10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G Occurrence Handle10091737

    Article  PubMed  Google Scholar 

  31. MH Wieneke ER Dienst (1995) ArticleTitleNeuropsychological assessment of cognitive functioning following chemotherapy for breast cancer Psychooncology 4 61–66

    Google Scholar 

  32. SB Schagen MJ Muller W Boogerd RM Rosenbrand D Rhijn Particlevan S Rodenhuis FS Dam Particlevan (2002) ArticleTitleLate effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients Ann Oncol 13 1387–1397 Occurrence Handle10.1093/annonc/mdf241 Occurrence Handle12196364

    Article  PubMed  Google Scholar 

  33. RT Chelebowski (2000) ArticleTitleReducing the risk of breast cancer N Engl J Med 343 191–198 Occurrence Handle10.1056/NEJM200007203430307 Occurrence Handle10900280

    Article  PubMed  Google Scholar 

  34. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah W Cronin A Vogel N Robidoux J Dimitrov M Atkins S Daly E Wieand L Tan-Chiu N Ford Wolmark InstitutionalAuthorNameother National Surgical Adjuvant Breast and Bowel Project Investigators (1998) ArticleTitleTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371–1388 Occurrence Handle9747868

    PubMed  Google Scholar 

  35. S Asthana LD Baker S Craft FZ Stanczyk RC Veith MA Raskind SR Plymate (2001) ArticleTitleHigh-dose estradiol improves cognition for women with AD: results of a randomized study Neurology 57 605–612 Occurrence Handle11524467

    PubMed  Google Scholar 

  36. PM Maki SM Resnick (2000) ArticleTitleLongitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition Neurobiol Aging 21 373–383 Occurrence Handle10.1016/S0197-4580(00)00123-8 Occurrence Handle10867223

    Article  PubMed  Google Scholar 

  37. SE Shaywitz BA Shaywitz KR Pugh RK Fulbright P Skudlarski WE Mencl RT Constable F Naftolin SF Palter K Marchione L Katz DP Shankweiler JM Fletcher C Lacadie M Keltz JC Gore (1999) ArticleTitleEffect of estrogen on brain activation patterns in postmenopausal women during working memory tasks JAMA 281 1197–1202 Occurrence Handle10.1001/jama.281.13.1197 Occurrence Handle10199429

    Article  PubMed  Google Scholar 

  38. B Sherwin (1997) ArticleTitleEstrogen effects on cognition in menopausal women Neurology 7 21–26

    Google Scholar 

  39. B Sherwin (1999) ArticleTitleCan estrogen keep you smart? Evidence from clinical studies J Psychiatry Neurosci 24 315–321 Occurrence Handle10516798

    PubMed  Google Scholar 

  40. F Grodstein J Chen DA Pollen MS Albert RS Wilson MF Folstein DA Evans MJ Stampfer (2000) ArticleTitlePostmenopausal hormone therapy and cognitive function in healthy older women J Am Geriatr Soc 48 746–752 Occurrence Handle10894312

    PubMed  Google Scholar 

  41. BE Sumner KE Grant R Rosie C Hegele-Hartung KH Fritzemeier G Fink (1999) ArticleTitleEffects of tamoxifen on serotonin transporter and 5-hydroxytryptamine (2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement Brain Res Mol Brain Res 73 119–28 Occurrence Handle10.1016/S0169-328X(99)00243-0 Occurrence Handle10581405

    Article  PubMed  Google Scholar 

  42. JC Arpels (1996) ArticleTitleThe female brain hypoestrogenic continuum from premenopausal syndrome to menopause J Reprod Med 41 633–639 Occurrence Handle8887186

    PubMed  Google Scholar 

  43. V Jenkins V Shilling L Fallowfield A Howell S Hutton (2004) ArticleTitleDoes hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study Psycho-Oncology 13 61–66 Occurrence Handle10.1002/pon.709 Occurrence Handle14745746

    Article  PubMed  Google Scholar 

  44. A Paganini-Hill LJ Clark (2000) ArticleTitlePreliminary assessment of cognitive function in breast cancer patients treated with tamoxifen Breast Cancer Res Treat 64 165–176 Occurrence Handle10.1023/A:1006426132338 Occurrence Handle11194452

    Article  PubMed  Google Scholar 

  45. Castellon SA, Ganz PA, Bower JE, Petersen L, Waddell K, Greendale G: Neurocognitive performance among breast cancer survivors: impact of treatment, reproductive factors, and mood. Paper presented at the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA., 2004. Abstract appears in American Society of Clinical Oncology Proceedings, 2004.

  46. IF Tannock TA Ahles PA Ganz FS Dam Particlevan (2004) ArticleTitleCognitive impairment associated with chemotherapy for cancer: report of a workshop J Clin Oncol 22 2233–2239 Occurrence Handle10.1200/JCO.2004.08.094 Occurrence Handle15169812

    Article  PubMed  Google Scholar 

  47. PA Ganz L Kwan AL Stanton JL Krupnick JH Rowland BE Meyerowitz JE Bower TR Belin (2004) ArticleTitleQuality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial J Natl Cancer Inst 96 376–387 Occurrence Handle14996859

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Greater Los Angeles VA Healthcare System, USA

    Steven A. Castellon

  2. Dept. of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, USA

    Steven A. Castellon

  3. Dept. of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, USA

    Daniel H. S. Silverman

  4. Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, USA

    Patricia A. Ganz

  5. Schools of Medicine and Public Health, University of California Los Angeles, USA

    Patricia A. Ganz

  6. Neuropsychiatric Institute & Hospital, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Steven A. Castellon

Authors
  1. Steven A. Castellon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel H. S. Silverman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia A. Ganz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven A. Castellon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castellon, S.A., Silverman, D.H.S. & Ganz, P.A. Breast Cancer Treatment and Cognitive Functioning: Current Status and Future Challenges in Assessment. Breast Cancer Res Treat 92, 199–206 (2005). https://doi.org/10.1007/s10549-005-5342-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-5342-0

Keywords

Search

Navigation